Management Team
Henning von Koss: Chief Executive Officer
During his 27 years with Bayer Material Science, Mr. von Koss served as senior vice president of Latin America, president and head of healthcare in the Andean region, and in numerous management positions in Brazil, Germany and Poland in addition to the Andean region. He recently served as chief operating officer of HAPVIDA, the third-largest managed care organization in Brazil with 20 hospitals, 70 clinics, 50 labs and 17,000+ employees, generating $3 billion turnover.
Scott Laitinen: Chief Financial Officer
Mr. Laitinen served as chief risk and operating officer of President’s Choice Financial and as chief financial officer and chief operating officer for Chase Card Services Canada. He was director of global business management and analysis for American Express (Amex) in addition to past roles with Canadian Imperial Bank of Commerce (CIBC) and Canada Post
Andrés Felipe Botero: Chief Operating Officer PharmaCielo Colombia
Mr. Botero was head of Philip Morris Andean Cluster for 20 years, overseeing cultivation, manufacturing, quality assurance, supply chain and distribution, and served as manager of Philip Morris International’s operations for reduced risk product portfolio in Colombia.
Board of Directors
Simon Langelier, Chairman of the Board
Mr. Langelier served in leadership capacities with Philip Morris International (PMI) and subsidiaries for over 30 years, most recently as the managing director of Coltabaco (Philip Morris Colombia) in Bogota, from 2010-11. He is a present member of the board of Imperial Brands PLC as an independent non-executive director.
Marc Lustig, Lead Director
Mr. Lustig founded CannaRoyalty Corp. (Origin House), which was sold to Cresco Labs in 2020, is currently executive chairman of IMC Cannabis, chairman of Trichome Financial Corp. and director of Cresco Labs. He served in the capital markets sector for 15 years, as director at GMP Securities, head of Capital Markets at Dundee Capital Markets and in the Life Sciences sector at Orion Securities. Previously, he worked in the pharmaceutical industry with Merck & Co.
Doug Bache, Director, Audit Committee Chair
Mr. Bache is a director and management consultant providing corporate finance and strategic advisory services to private and public companies. He has held senior management positions at Vale/Inco Limited and North American Palladium and investment and corporate banking roles with CIBC World Markets and Société Générale Canada.
Dr. Claudia Jiménez, Director
Dr. Jiménez is a lawyer with Jiménez & Asociados S.A.S., a private consultancy firm. She has served as Minister-Counselor for the President of Colombia, Ambassador in Switzerland and Liechtenstein, Executive Director of the Mining Colombian Association (SMGE) and Professor at the University Externado de Colombia and is a member of the board of ISA InterColombia, Executive Director of the Dialogue Group of Mining in Colombia (GDIAM) and a former board member of Empresas Públicas de Medellín (EPM) and TSX-listed Continental Gold. She completed a Doctorate of Law at the Université of Paris II (Panthéon-Assas), France and Law and Political Science degree at the Universidad Pontificia Bolivariana in Medellín.
Matteo Pellegrini, Director
Mr. Pellegrini has over 25 years of international management and leadership experience with Philip Morris International in numerous European and Asian countries. He served from 2003 to 2015 as Philip Morris International’s president of Asia.
Henning von Koss, Director
During his 27 years with Bayer Material Science, Mr. von Koss served as senior vice president of Latin America, president and head of healthcare in the Andean region, and in numerous management positions in Brazil, Germany and Poland in addition to the Andean region. He recently served as chief operating officer of HAPVIDA, the third-largest managed care organization in Brazil with 20 hospitals, 70 clinics, 50 labs and 17,000+ employees, generating $3 billion turnover.
